The Group packages and sells a number of these products under its own?label names. Delivering a fully integrated management team that shares a common strategy and philosophy, the Company has 4 Sales and Marketing divisions for own-label products, representing different geographical areas.

The Group?s biggest ?own-label? markets are the US, Turkey, Bulgaria, Russia and the CIS, Germany, UK, the Nordic countries and Serbia.

Actavis? broad product portfolio of over 830 products encompasses all of the major therapeutic areas and formulations. In addition to tablets and capsules, Actavis sells injectables, suspensions, infusions, suppositories, gels, syrups, creams and ointments.